NM_012228.4:c.296+3068A>G
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_012228.4(MSRB2):c.296+3068A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.898 in 152,112 control chromosomes in the GnomAD database, including 61,969 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.90 ( 61969 hom., cov: 31)
Consequence
MSRB2
NM_012228.4 intron
NM_012228.4 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -1.69
Publications
1 publications found
Genes affected
MSRB2 (HGNC:17061): (methionine sulfoxide reductase B2) Predicted to enable actin binding activity; peptide-methionine (R)-S-oxide reductase activity; and zinc ion binding activity. Predicted to be involved in actin filament polymerization and protein repair. Predicted to be located in mitochondrion. Predicted to be active in cytoplasm. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-1.0).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.952 is higher than 0.05.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| MSRB2 | ENST00000376510.8 | c.296+3068A>G | intron_variant | Intron 3 of 4 | 1 | NM_012228.4 | ENSP00000365693.3 | |||
| MSRB2 | ENST00000472663.1 | n.176+3068A>G | intron_variant | Intron 2 of 4 | 5 | ENSP00000434990.1 | ||||
| ENSG00000286924 | ENST00000655462.1 | n.116+20303T>C | intron_variant | Intron 1 of 1 |
Frequencies
GnomAD3 genomes AF: 0.898 AC: 136468AN: 151994Hom.: 61930 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
136468
AN:
151994
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.898 AC: 136559AN: 152112Hom.: 61969 Cov.: 31 AF XY: 0.893 AC XY: 66427AN XY: 74366 show subpopulations
GnomAD4 genome
AF:
AC:
136559
AN:
152112
Hom.:
Cov.:
31
AF XY:
AC XY:
66427
AN XY:
74366
show subpopulations
African (AFR)
AF:
AC:
35532
AN:
41430
American (AMR)
AF:
AC:
12866
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
AC:
3281
AN:
3470
East Asian (EAS)
AF:
AC:
2557
AN:
5154
South Asian (SAS)
AF:
AC:
3978
AN:
4820
European-Finnish (FIN)
AF:
AC:
10124
AN:
10616
Middle Eastern (MID)
AF:
AC:
266
AN:
294
European-Non Finnish (NFE)
AF:
AC:
65180
AN:
68022
Other (OTH)
AF:
AC:
1900
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
641
1282
1924
2565
3206
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
892
1784
2676
3568
4460
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2530
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.